1. Home
  2. NLSP vs MGRX Comparison

NLSP vs MGRX Comparison

Compare NLSP & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • MGRX
  • Stock Information
  • Founded
  • NLSP 2015
  • MGRX 2021
  • Country
  • NLSP Switzerland
  • MGRX United States
  • Employees
  • NLSP N/A
  • MGRX N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • MGRX Computer Software: Prepackaged Software
  • Sector
  • NLSP Health Care
  • MGRX Technology
  • Exchange
  • NLSP Nasdaq
  • MGRX Nasdaq
  • Market Cap
  • NLSP 8.2M
  • MGRX 9.3M
  • IPO Year
  • NLSP 2021
  • MGRX 2023
  • Fundamental
  • Price
  • NLSP $0.20
  • MGRX $0.35
  • Analyst Decision
  • NLSP Hold
  • MGRX
  • Analyst Count
  • NLSP 1
  • MGRX 0
  • Target Price
  • NLSP N/A
  • MGRX N/A
  • AVG Volume (30 Days)
  • NLSP 29.2M
  • MGRX 896.1K
  • Earning Date
  • NLSP 07-23-2024
  • MGRX 07-26-2024
  • Dividend Yield
  • NLSP N/A
  • MGRX N/A
  • EPS Growth
  • NLSP N/A
  • MGRX N/A
  • EPS
  • NLSP N/A
  • MGRX N/A
  • Revenue
  • NLSP N/A
  • MGRX $844,866.00
  • Revenue This Year
  • NLSP N/A
  • MGRX N/A
  • Revenue Next Year
  • NLSP N/A
  • MGRX N/A
  • P/E Ratio
  • NLSP N/A
  • MGRX N/A
  • Revenue Growth
  • NLSP N/A
  • MGRX 670.43
  • 52 Week Low
  • NLSP $0.11
  • MGRX $0.14
  • 52 Week High
  • NLSP $1.21
  • MGRX $1.95
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 53.60
  • MGRX 51.19
  • Support Level
  • NLSP $0.18
  • MGRX $0.32
  • Resistance Level
  • NLSP $0.22
  • MGRX $0.40
  • Average True Range (ATR)
  • NLSP 0.04
  • MGRX 0.03
  • MACD
  • NLSP -0.00
  • MGRX 0.00
  • Stochastic Oscillator
  • NLSP 15.48
  • MGRX 43.40

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Share on Social Networks: